Seeking Alpha

Supernus Pharmaceuticals, Inc. (SUPN)

  • Quantified Alpha | Send Message 15 Apr

    $SUPN is that rare pharma that has huge price momentum combined with profitability & growth
      • Young Money Monsters | Send Message 10 Mar

        Our Analyst Extensively Breaks Down Today's News and Market Movers: $HABT $SUPN $GILD $GLW $NVDA $MBLY $AAPL $BP
          • IndyPEG | Send Message 9 Mar
              • IndyPEG | Send Message 4 Mar

                $SUPN at it hard leading up to E/R
                  • ONeil Trader | Send Message 24 Feb

                    Supernus: A Specialty Pharma With Significant Growth Potential $SUPN
                      • Eric Muathe | Send Message 13 Oct 2014

                        SHORT IDEAS [ Per VIDEO ]: $AGU $CMI $FEIC $FLY $NSLP $RAS $REGI $SUPN $SWHC
                        Reply (1)
                        • Travis Brown | Send Message 21 Oct 2014
                          : Shorting $SWHC? Scary.
                          • vit777 | Send Message 27 Sep 2014

                            $SUPN - hope for 50% upside before EOY. Great results in 2014, it looks like they will double on revenue in 2015
                              • Eric Muathe | Send Message 25 Sep 2014

                                SHORT IDEAS [ As Per VIDEO ]: $DSX $FLY $HPT $NTI $REGI $RGR $SAM $SUPN $TGH
                                  • sdanderson21 | Send Message 12 Sep 2014

                                    Wow how much can people short this stock $SUPN
                                      • freefdawatchlist | Send Message 4 Sep 2014

                               Volatile Stock (Risky Stock): $STXS, $SUPN, $MITK, $HGSH, $DGLY, $JRJC, $ISNS, $VII, $SGOC
                                          Visit Seeking Alpha's
                                          SUPN vs. ETF Alternatives
                                          Company Description
                                          Supernus Pharmaceuticals Incis a specialty pharmaceutical company. The Company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.
                                          Sector: Healthcare
                                          Industry: Drugs - Generic
                                          Country: United States